Skip to main content
. 2022 Jan 10;10:5. doi: 10.1186/s40478-021-01308-1

Fig. 3.

Fig. 3

Overall survival (Kaplan–Meier curve) of patients in cohort mcPXA stratified after CNS WHO grade (a) and pTERT status (b, c). (b) includes tumors classified via the brain tumor classifier and (c) includes tumors classified via tSNE. pTERT mutant mcPXA revealed significantly worse overall survival compared to wild type mcPXA (log rank P* < 0.0001). CNS WHO grade did not show any prognostic significance in mcPXAs (log rank P > 0.05)